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Abstract
Background: Empiric programming of the atrio-ventricular (AV) delay is commonly performed 
during pacemaker implantation. Transmitral flow assessment by Doppler echocardiography can 
be used to find the optimal AV delay by Ritter's method, but this cannot easily be performed 
during pacemaker implantation. We sought to determine a non-invasive surrogate for this 
assessment. Since electrocardiographic P-wave duration estimates atrial activation time, we 
hypothesized this measurement may provide a more appropriate basis for programming AV 
intervals.
Methods:  A total of 19 patients were examined at the time of dual chamber pacemaker 
implantation, 13 (68%) being male with a mean age of 77. Each patient had the optimal AV 
interval determined by Ritter's method.  The P-wave duration was measured independently on 
electrocardiograms   using   MUSE®   Cardiology   Information   System   (version   7.1.1).   The 
relationship between P-wave duration and the optimal AV interval was analyzed.          
Results:  The P-wave duration and optimal AV delay were related by a correlation coefficient 
of 0.815 and a correction factor of 1.26. The mean BMI was 27. The presence of hypertension, 
atrial fibrillation, and valvular heart disease was 13 (68%), 3 (16%), and 2 (11%) respectively. 
Mean echocardiographic parameters included an ejection fraction of 58%, left atrial index of 32 
ml/m2, and diastolic dysfunction grade 1 (out of 4).                                         
Conclusions: In patients with dual chamber pacemakers in AV sequentially paced mode and 
normal EF, electrocardiographic P-wave duration correlates to the optimal AV delay by Ritter's 
method by a factor of 1.26.                                                                                               
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Introduction  
The implantation of a dual chamber pacemaker may serve as an alternate timing mechanism for 
the conduction system of the heart. These devices try to mimic intrinsic automaticity, and they 
also allow adjustment of the timing of the atrio-ventricular excitation sequence.  As such, the 
effects   of   DDD   programming   pacing   affects   right   heart   hemodynamics,   and   due   to 
interventricular dependence impacts left heart hemodynamics [1,2]. To optimize left ventricular 
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filling in these patients, the AV delay must be programmed short enough to avoid premature 
mitral valve closure with mitral regurgitation, and long enough to avoid left atrial cannon waves 
[3,4].   Techniques   such   as   impedance   cardiography   [4,5]   and   analysis   of   aortic   valve 
hemodynamics [6] have utility in assisting the programmer to define the optimum timing 
interval.  In patients with complete heart block and DDD pacemakers, the Ritter method is one 
of several methods used to optimize the AV delay by synchronizing left atrial and ventricular 
contractions to allow for maximal cardiac output [7].  The Ritter method has also been applied 
to patients with preserved and reduced ejection fractions [3], and for cardiac resynchronization 
therapy [8,9].                                                                                                                     
 
The P-wave duration has been shown to correlate to interatrial conduction time with the initial 
and terminal portions of the P wave corresponding to the right and left atrial activation 
respectively   [10-13].   However,   interatrial   conduction   times   vary   significantly   between 
individuals,   thereby   influencing   the   optimal   AV   interval   [12,14,15].   Atrioventricular 
conduction is also known to be variable, manifested by beat-to-beat PR interval variability in 
patients with and without coronary artery disease [16]. In addition, the influence of the 
autonomic nervous system on atrioventricular conduction is well described [17,18]. The size of 
the   person's   body   has   minimal   effect   on   the   PR   interval   [19].   These   interatrial   and 
atrioventricular conduction variabilities have implications for the optimal timing of DDD 
pacing. Allowing for a fixed electromechanical coupling interval, P-wave duration and optimal 
AV interval is likely to have a reproducible relationship. The goal of our study was to evaluate 
if electrocardiographic P-wave duration would correlate with optimal AV delay as calculated by 
Ritter's method.                                                                                                   
Materials and Methods                                                                                                 
Nineteen patients with dual chamber pacemakers were included in the study.  All patients had 
prolonged PR interval (> 200 ms) or high degree AV block.  No fusion or pseudofusion was 
present during measurements taken at rest.  Baseline characteristics of the study group were 
collected.  To verify placement of the atrial lead in the right atrial appendage and the right 
ventricular lead in the right ventricular apex, the operative fluoroscopy and post-procedure 
chest x-ray films were reviewed.                                                                                           
Echocardiograms   were   obtained   in   the   left   lateral   decubitus   position   using   a   Vivid-I 
Cardiovascular Ultrasound (GE Healthcare, Milwaukee, Wisconsin).  The apical 4-chamber and 
2-chamber views were used from end-diastole and end-systole for calculation of ejection 
fraction and left atrial volume.  The left atrial index was determined by dividing the left atrial 
volume by the body mass index.  Grading of diastolic dysfunction was carried out by previously 
published criteria [20].                                                                                               
The optimal AV delay was calculated using an AV paced rhythm with the Ritter method, based 
on pulsed wave Doppler echocardiography of the transmitral blood flow (Figure 1) [7]. This 
method requires several steps. First, the pacemaker is programmed to a non-physiologically 
short AV delay, causing mitral valve closure to occur with the onset of left ventricular 
contraction. This value "a" is the longest interval, encompassing the ventricular pacing artifact 
to the end of the A wave in the mitral flow velocity ("a" is the electromechanical delay between 
right ventricular stimulation and the beginning of the left ventricular systole). Next, the 
pacemaker is programmed to a long AV delay to determine "b". This value "b" includes the 
time interval between the ventricular pacing artifact and the end of the A wave. By correcting 
the long AV delay by the values "a" and "b", the timing of ventricular systole can be optimized 
to allow for maximum diastolic ventricular filling.  The calculation of the optimal AV interval 
(AVopt = AVlong – [a – b]) thereby prevents the occurrence of left atrial cannon waves and 
diastolic mitral regurgitation.
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Figure 1. Calculation of Optimal Atrioventricular (AV) Delay by Mitral Inflow Pattern. While using Doppler 
echocardiography, the pacemaker is programmed to a non-physiologically short AV delay.   The value "a" 
encompasses the time interval between ventricular pacing artifact to the end of the A wave in the mitral flow.  The 
pacemaker is then programmed to a long AV delay.  The value "b" includes the time interval between the end of 
the A wave and the ventricular pacing artifact.  The optimal AV interval is then calculated by subtracting "b" from 
"a" and subtracting this calculated value from the long AV delay value.                                                   
For   P-wave   duration,   the   ECG   obtained   prior   to   device   implantation   was   used   for 
measurements. A 12-lead standard surface electrocardiogram (10 mm/mV, 25 mm/s) was 
obtained in the supine resting position using a computer-based ECG system (MUSE® 
Cardiology Information System, Version 7.1.1, General Electric, Milwaukee, Wisconsin). 
Subjects were breathing freely during acquisition, but not allowed to speak. The MUSE® 
program calipers were used to measure the P wave in leads II and V1, and the operator was 
blinded to echocardiographic findings.  The onset and offset of the P wave were defined as the 
start of the upward deflection of the P-wave pattern and its return to the isoelectric baseline in 
lead II [21]. Right atrial abnormality was defined as a P-wave height greater than 2.5 mm in 
lead II. Left atrial abnormality was defined as P-wave duration greater than 120 ms in lead II or 
a negative deflection greater than 1 mm of the P wave in lead V1 [22]. The P-wave duration 
was then plotted against the optimal AV delay and other baseline characteristics and findings.  
Regression analysis was performed.                                                                                                
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Informed consent was obtained from all study participants, and this study was approved by the 
Mayo Foundation Institutional Review Board.                                                                       
Results
There were 19 patients, 13 male and 6 female, mean age 77 +/- 5 years.    The average BMI was 
27.  A history of atrial fibrillation was present in 3 (16%) patients.  Ten patients had left atrial 
enlargement on echocardiography, with the mean left atrial index being 32 ml/m2.   On 
electrocardiogram, right and left atrial abnormalities were present in 0 (0%) and 12 (63%) 
patients respectively.  Other baseline characteristics are summarized in Table 1.  A summary of 
pacemakers used is included in Table 2.  
Table 1.  Clinical characteristics of the patients
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Table 2.  Pacemaker Models, Manufacturers, and Number
The average P-wave duration on electrocardiogram was 113 ± 19 ms, ranging from 88 to 140 
ms.  For patients with a history of atrial fibrillation, the P-wave duration was 95 ± 12 ms. 
Patients with electrocardiographic left atrial abnormality had a mean P-wave duration of 120 ± 
19 ms.  In patients with left atrial enlargement on echocardiogram, the mean P-wave duration 
was 119 ± 20 ms.  Overall, the mean heart rate and PR interval were 53 ± 13 bpm and 201 ± 34 
ms respectively.  The optimal AV delay calculated by Ritter's method was 142 ± 40 ms for all 
patients. Other optimal AV delay calculated for the presence of any interventricular conduction 
delay is summarized in Table 3.
Table 3.  Relation of ECG characteristics to optimal AV delay
The correlation coefficient for the P-wave duration and optimal AV delay was 0.815 (Figure 
2).  Dividing the mean optimal AV delay by the mean P wave duration gives a ratio of 1.26 ± 
0.24 ms   for  the  entire  cohort. In  patients  with  LBBB  and  nonspecific  interventricular 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 10 (9): 383-392 (2010)Dan Sorajja, Mayurkumar D Bhakta, Luis RP Scott, Gregory T Altemose,             388 
Komandoor Srivathsan,  “Utilization of Electrocardiographic P-wave Duration for AV 
Interval Optimization in Dual-Chamber Pacemakers”
conduction delay, the ratio was similar, 1.11 to 1.13. In patients with RBBB and those without 
any interventricular conduction delay, the ratio was similar 1.31 (Table 3). The optimal AV 
delay did not correlate to the left atrial index (R2 = 0.21), electrocardiographic heart rate (R2 = 
0.07), or electrocardiographic PR interval (R2 = 0.26).
Figure 2. Correlation of P Wave Duration to Optimal Atrioventricular (AV) Delay. The plot was constructed using 
P-wave durations and optimal AV delay as determined by Ritter’s method.  The correlation coefficient is high, 
indicating that optimal AV delay can be predicted from P-wave duration in patients with dual-chamber 
pacemakers.
Discussion
For   patients   undergoing   dual   chamber   pacemaker   implantation,   measurement   of   the 
electrocardiographic P-wave duration correlates by a ratio of 1.26 to the optimal AV delay by 
Ritter's method when pacemaker is in AV sequential pacing mode.  This ratio gives clinicians a 
useful tool to program the AV delay based on the electrocardiographic P wave duration.  
By adding one-fourth of the P-wave duration to its baseline measurement, device implanters and 
programmers can calculate the likely optimal AV delay during AV pacing within a reasonable 
degree of certainty.  This calculation provides an alternative to the use of empiric device settings 
that may not be hemodynamically suitable for individual patients.  This calculation is unlikely to 
replace   cardiac   output   optimization   methods   such   as   echocardiography   in   dual-chamber 
pacemaker patients, but implementation of this calculation could improve cardiac hemodynamics 
in patients who have yet to undergo such optimization methods, which requires time, availability, 
and a trained echocardiographer to perform [23]. While many patients will likely not suffer any 
serious consequences with programming of the AV delay slightly shorter or longer than the 
optimal AV delay, the improvement by this simple optimization method could potentially 
improve hemodynamics in many of them.   For patients with dual chamber pacemakers, the 
optimal AV  interval  can  lead to significant  improvement  in mechanical  atrio-ventricular 
synchrony and quality of life [4,24,25]. The late diastolic mitral regurgitation, seen with  first-
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degree heart block and complete heart block, can be reduced or eliminated with AV delay 
optimization leading to improved stroke volume, which may benefit heart failure patients in 
particular [3,26]. For these reasons among others, empiric programming of the AV interval is not 
recommended [27,28]. However, the benefit of AV synchrony may not be apparent if the right 
ventricle is frequently paced to maintain this synchrony. With high burdens of right ventricular 
pacing, interventricular dyssynchrony may develop and reduce cardiac output and function, 
particularly those patients with congestive heart failure [29,30]. However, the vast majority of 
patients will not have their left ventricular ejection fraction compromised by frequent right 
ventricular pacing [31], The utility of AV interval programming based on P-wave duration as 
suggested in this study is beneficial for patients with AV conduction abnormalities who are in 
AV   sequential   pacing   mode.                                                                              
Acceptable intraobserver and interobserver measurement of P wave duration has been shown in a 
number of studies [32-34].  In addition, the computerized on-screen measurement of P-wave 
duration (including the MUSE system as used in this study) has been reported to have the lowest 
intraobserver and interobserver variability with an error of 3 ± 2.9%, superior in comparison to 
both manual measurement of P-wave duration in electrocardiograms magnified 200% and high 
resolution digitizing board with on-board measurement of P-wave duration [21].             
 
Although electrocardiographic P-wave duration is known to correlate to interatrial conduction 
times in sinus and right atrial pacing modes [14], certain patient groups may benefit from a 
shorter or longer AV delay in relation to the P wave duration depending on factors such as lead 
placement location, sinus versus paced rhythm, and interventricular delay. All of our patients had 
the right atrial lead placed in the appendage, which is a known contributor to interatrial 
conduction delay. Patients with the right atrial leads placed septally would likely need shorter AV 
delays programmed [13]. Shorter calculated AV delays may also be necessary if the terminal 
component of the P wave is felt to represent pulmonary vein activation, and not atrial activation 
[35]. Inclusion of the terminal portion of the P wave in these cases would lead to overestimation 
of the optimal AV delay.  Patients who pace the majority of time in an atrial tracking mode may 
require a shorter AV interval, since interatrial conduction times prolong with right atrial pacing 
when compared to sinus rhythm.   In one study of patients with electrocardiographic P-wave 
duration of less than 110 ms and greater than 110 ms, the average interatrial conduction time 
lengthened 26 and 27 ms on average respectively with right atrial pacing [14]. However, 
detection of a P wave by a pacemaker in an atrial-sensing mode takes an average of 30 ms [2]. 
The lengthening of the interatrial conduction time with atrial pacing may offset the delay in 
detection of a P wave during an atrial-sensing mode but these intervals substantially differ from 
patient to patient and this difference has to be taken in consideration in programming the AV 
delay.  Also, the interatrial conduction time is nearly constant at all atrial paced rates between 80 
to 160 bpm, varying only 7 ms, so further adjustment to the optimal AV delay based on the 
pacing rate may not be necessary [14].                                                                       
 
Patients with a history of paroxysmal atrial fibrillation may benefit from a longer correction 
factor to calculate the optimal AV delay, since these patients typically have an increased P wave 
duration when in sinus rhythm although this was not seen in our limited patient cohort [21,32,36].
 
Limitations of this study include the small study population in a tertiary medical center. With the 
limited number of patients, the current study could be considered a pilot study and application to 
larger populations needs further investigation. Although some referral-related bias may be 
present, our patients have characteristics in common with patients that would be seen in a general 
practice.    Specific   measurements   of   P-wave   sensing   delay,   paced   interatrial   delay,   and 
interventricular delay were not measured in individual patients.   Optimizing the AV delay for 
both exercise and increased heart rate was also not performed in our cohort, although rate-
adaptive shortening of the AV delay is of known benefit in patients with DDDR pacemakers with 
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normal ejection fractions [28]. No long term follow-up was undertaken after programming of the 
device to the optimal AV delay.  While our study correlates the P-wave duration to the optimal 
AV delay, no specific analysis on cardiac output or hemodynamics was performed.  Analysis of 
the effect of the optimal AV delay on cardiac hemodynamics, quality of life, and other 
parameters would require another study design.  The reproducibility of our findings may also 
depend on the availability of computerized on-screen measurement of ECG parameters, including 
the P wave, as well as having P waves large and distinct enough to measure in patients.  In 
patients with no visible P waves, this data is not   applicable.                                          
Our study shows the P-wave duration correlates to the optimal AV delay as calculated by Ritter's 
method by a factor of 1.26.  Using this ratio, clinicians can determine an individual's optimal AV 
delay based on a patient's own electromechanical activation. Our simple calculation gives 
clinicians a useful tool that should benefit patients beyond empiric device settings, which may not 
be hemodynamically suitable for patients.  With the limited number of patients, the current study 
could   be   considered   a   pilot   study   and   application   to   larger   populations   needs   further 
investigation.
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